Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study
Summary: Background: The effectiveness of heterologous prime-boost Coronavirus disease 2019 (Covid-19) vaccination is currently unknown. Methods: From individuals vaccinated with two doses against Covid-19 in Sweden until July 5, 2021 (N=3,445,061), we formed a study cohort including 94,569 individ...
Guardado en:
Autores principales: | Peter Nordström, Marcel Ballin, Anna Nordström |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d2b2b1b5117f49ecb1e56dfeb11de756 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19
por: Chiara Agrati, et al.
Publicado: (2021) -
Thromboses of major arteries and ChAdOx1 nCov-19 vaccination
por: Rujittika Mungmunpuntipantip, et al.
Publicado: (2021) -
Severe but Self-Limiting Polyarthralgia with Functional Impairment Following ChAdOx1 nCov-19 Vaccination in an Elderly Recipient
por: Joel Ern Zher Chan, et al.
Publicado: (2021) -
Potential global impacts of alternative dosing regimen and rollout options for the ChAdOx1 nCoV-19 vaccine
por: Ricardo Aguas, et al.
Publicado: (2021) -
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models
por: Teresa Lambe, et al.
Publicado: (2021)